Editorial |

Progress in Infectious Disease and Immunology

Gianna Zuccotti, MD, MPH; Phil B. Fontanarosa, MD, MBA
JAMA. 2011;305(14):1486-1487. doi:10.1001/jama.2011.452.
Text Size: A A A
Published online


Infectious diseases are commonly encountered in virtually all areas of health care, can represent potential major threats to communities and public health, and account for substantial morbidity and mortality. On a global level, infectious diseases such as malaria and tuberculosis remain leading causes of death.1 Among hospitalized patients, infectious complications such as central line–associated bloodstream infections, ventilator-associated pneumonia, and surgical site infections continue to be important causes of morbidity and increased length of stay. Illness related to infectious diseases also accounts for significant numbers of office and emergency department visits as well as substantial heath care costs and leads to losses in productivity among workers. In addition, the management of infectious diseases continues to be challenging, with major concerns about the emergence of multidrug-resistant pathogens and a significant decline in the production of new antimicrobial agents from both research and industry sources.2

Sign In to Access Full Content

Don't have Access?

Register and get free email Table of Contents alerts, saved searches, PowerPoint downloads, CME quizzes, and more

Subscribe for full-text access to content from 1998 forward and a host of useful features

Activate your current subscription (AMA members and current subscribers)

Purchase Online Access to this article for 24 hours

First Page Preview

View Large
First page PDF preview




Meets CME requirements for:
Browse CME for all U.S. States
Accreditation Information
The American Medical Association is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians. The AMA designates this journal-based CME activity for a maximum of 1 AMA PRA Category 1 CreditTM per course. Physicians should claim only the credit commensurate with the extent of their participation in the activity. Physicians who complete the CME course and score at least 80% correct on the quiz are eligible for AMA PRA Category 1 CreditTM.
Note: You must get at least of the answers correct to pass this quiz.
You have not filled in all the answers to complete this quiz
The following questions were not answered:
Sorry, you have unsuccessfully completed this CME quiz with a score of
The following questions were not answered correctly:
Commitment to Change (optional):
Indicate what change(s) you will implement in your practice, if any, based on this CME course.
Your quiz results:
The filled radio buttons indicate your responses. The preferred responses are highlighted
For CME Course: A Proposed Model for Initial Assessment and Management of Acute Heart Failure Syndromes
Indicate what changes(s) you will implement in your practice, if any, based on this CME course.
Citing articles are presented as examples only. In non-demo SCM6 implementation, integration with CrossRef’s "Cited By" API will populate this tab (http://www.crossref.org/citedby.html).


Some tools below are only available to our subscribers or users with an online account.

Sign In to Access Full Content

Related Content

Customize your page view by dragging & repositioning the boxes below.

Articles Related By Topic
Related Topics
PubMed Articles
Anti-mycobacterial activity of 1,3-diaryltriazenes. Eur J Med Chem Published online Mar 1, 2014.;